main-logo

ICD-10 Code D03.72 | Melanoma in situ of left lower limb, including hip Symptoms, Diagnosis, Billing

Melanoma in situ of the left lower limb, including the hip, is a localized skin cancer that arises from melanocytes. It is characterized by the uncontrolled growth of these pigment-producing cells and is often caused by UV exposure. Accurate coding with ICD-10 Code D03.72 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that patients receive appropriate care and resources.

What is ICD-10 Code D03.72 for Melanoma in situ of left lower limb, including hip?

ICD-10 Code D03.72 specifically denotes melanoma in situ located on the left lower limb, including the hip. This code is used when documenting cases of melanoma that have not invaded deeper tissues but require monitoring and potential intervention. It is crucial for accurate clinical documentation and billing, particularly in dermatology and oncology settings.

ICD-10 Code D03.72 – Clinical Definition and Explanation of Melanoma in situ of left lower limb, including hip

Melanoma in situ of the left lower limb, including the hip, is a non-invasive form of skin cancer that can progress to invasive melanoma if left untreated. It is primarily caused by ultraviolet radiation exposure and necessitates prompt medical evaluation and treatment to prevent progression.

Key Clinical Features:

  • Asymmetrical moles or lesions
  • Irregular borders and varied color
  • Itching or bleeding from the lesion
  • History of excessive sun exposure

ICD-10 Code D03.72 for Melanoma in situ of left lower limb, including hip – SOAP Notes & Clinical Use

ICD-10 Code D03.72 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. It plays a vital role in both acute and chronic care settings, ensuring comprehensive patient management and accurate billing.

What Does ICD-10 Code D03.72 for Melanoma in situ of left lower limb, including hip Mean in SOAP Notes?

In SOAP notes, ICD-10 Code D03.72 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of melanoma in situ. This code is essential for continuity of care, supporting billing processes, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code D03.72 – Melanoma in situ of left lower limb, including hip

Prompt treatment of melanoma in situ is crucial to prevent progression to invasive melanoma. Surgical excision is the primary treatment modality.

Antibiotic Therapy:

  • Not applicable for melanoma in situ

Supportive Care:

  • Regular follow-up for monitoring
  • Patient education on skin protection
  • Psychosocial support as needed

Infection Control:

  • Standard precautions during surgical procedures
  • Education on wound care post-excision

How to Document Symptoms of Melanoma in situ of left lower limb, including hip (ICD-10 D03.72) in SOAP Notes

Subjective:

  • Patient reports a new mole on the left lower limb
  • Lesion has changed in color and size over the past month
  • Patient notes occasional itching at the site
  • No history of trauma to the area

Objective:

  • Lesion on left lower limb measuring 1.5 cm
  • Irregular borders and multiple colors observed
  • No signs of ulceration or bleeding
  • Dermatoscopic examination shows atypical features
card-topcard-bottom

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more
hipaa-icon

SOAP Note Guidelines for Diagnosing Melanoma in situ of left lower limb, including hip (ICD-10 Code D03.72)

Assessment:

  • Diagnosis: Melanoma in situ of left lower limb, including hip, classified as D03.72
  • Severity: Non-invasive
  • Contributing factors: History of sun exposure
  • Patient education on skin monitoring

Plan:

  • Surgical excision of the lesion
  • Follow-up appointment in 4-6 weeks
  • Patient education on sun protection and skin checks
  • Consider referral to oncology for further management if indicated

Treatment & Plan Section for ICD-10 Code D03.72 – Melanoma in situ of left lower limb, including hip

  • Surgical excision is the primary treatment
  • Regular dermatological follow-ups are essential
  • Patient education on skin self-examination
  • Monitoring for any changes in skin lesions

Using ICD-10 Code D03.72 for Melanoma in situ of left lower limb, including hip in Billing & SOAP Note Compliance

  • Ensure accurate documentation of symptoms and findings in SOAP notes
  • Use D03.72 for billing related to dermatology and oncology services
  • Align treatment plans with clinical guidelines to support billing
  • Include relevant CPT codes that correspond to the services provided

ICD-10 Code D03.72 in Medical Billing and Insurance for Melanoma in situ of left lower limb, including hip

ICD-10 Code D03.72 is critical for accurate billing in hospital, ER, or oncology settings.

Billing Notes:

  • Document all relevant clinical findings to support the diagnosis
  • Use D03.72 in conjunction with appropriate CPT codes for procedures
  • Ensure compliance with payer requirements for documentation
  • Review coding guidelines regularly to maintain accuracy

Common CPT Pairings:

CPT CodeDescription
11400Excision, benign lesion, face, ears, scalp, neck; excised diameter up to 2.0 cm
11600Excision, malignant skin lesion, face, ears, scalp, neck; excised diameter up to 1.0 cm
99213Established patient office visit, Level 3

Frequently Asked Questions

Common Questions About Using ICD-10 Code D03.72 for Melanoma in situ of left lower limb, including hip

What are the risk factors for melanoma in situ?

Risk factors for melanoma in situ include excessive sun exposure, a history of sunburns, fair skin, and a family history of skin cancer. Regular skin checks are recommended for individuals with these risk factors.

How is melanoma in situ treated?

Melanoma in situ is primarily treated through surgical excision of the lesion. Follow-up care is essential to monitor for any recurrence or new lesions.

Is melanoma in situ contagious?

No, melanoma in situ is not contagious. It is a type of skin cancer that arises from genetic mutations in skin cells, primarily due to UV exposure.

What is the prognosis for melanoma in situ?

The prognosis for melanoma in situ is generally excellent when detected early and treated appropriately. The risk of progression to invasive melanoma is significantly reduced with timely intervention.

diamond-bg
diamond-bg

Get started with your 20 free notes

Sign up for free
main-logo

AI-aided Sudsy Shorthand for ink-free practices

support@soapsuds.io
hipaa-logo

Clinical Notes

SOAP notes

DAP notes

AI medical notes

© Copyright SOAPsuds 2025. All rights reserved